KBC Group’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,266
| Closed | -$14K | – | 1880 |
|
|
2023
Q3 | $14K | Sell |
1,266
-320
| -20% | -$3.54K | ﹤0.01% | 1907 |
|
|
2023
Q2 | $34K | Hold |
1,586
| – | – | ﹤0.01% | 1431 |
|
|
2023
Q1 | $64K | Hold |
1,586
| – | – | ﹤0.01% | 1331 |
|
|
2022
Q4 | $74K | Hold |
1,586
| – | – | ﹤0.01% | 1301 |
|
|
2022
Q3 | $82K | Hold |
1,586
| – | – | ﹤0.01% | 1261 |
|
|
2022
Q2 | $75K | Hold |
1,586
| – | – | ﹤0.01% | 1327 |
|
|
2022
Q1 | $113K | Buy |
+1,586
| New | +$113K | ﹤0.01% | 1156 |
|
|
2019
Q4 | – | Sell |
-12,843
| Closed | -$772K | – | 1509 |
|
|
2019
Q3 | $772K | Sell |
12,843
-9,104
| -41% | -$547K | 0.01% | 956 |
|
|
2019
Q2 | $1.85M | Sell |
21,947
-1,350
| -6% | -$114K | 0.01% | 625 |
|
|
2019
Q1 | $2.23M | Sell |
23,297
-18,124
| -44% | -$1.73M | 0.02% | 594 |
|
|
2018
Q4 | $2.93M | Buy |
41,421
+20,198
| +95% | +$1.43M | 0.03% | 444 |
|
|
2018
Q3 | $1.81M | Buy |
+21,223
| New | +$1.81M | 0.01% | 713 |
|